|
Erlebacher, A (2001) Why isn't the fetus rejected? Curr Opin Immunol 13:590-3
|
|
de Bont, E S; Reilly, C R; Lo, D et al. (1999) A minimal level of MHC class II expression is sufficient to abrogate autoreactivity. Int Immunol 11:1295-306
|
|
Laufer, T M; Fan, L; Glimcher, L H (1999) Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. J Immunol 162:5078-84
|
|
Laufer, T M; Glimcher, L H; Lo, D (1999) Using thymus anatomy to dissect T cell repertoire selection. Semin Immunol 11:65-70
|
|
Laufer, T M; Smiley, S T; Ranger, A et al. (1997) Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation. J Immunol 159:5914-20
|
|
Steele, D J; Laufer, T M; Smiley, S T et al. (1996) Two levels of help for B cell alloantibody production. J Exp Med 183:699-703
|
|
Tarleton, R L; Grusby, M J; Postan, M et al. (1996) Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol 8:13-22
|
|
Zhao, J; Freeman, G J; Gray, G S et al. (1996) A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB. J Exp Med 183:777-89
|
|
Chakkalath, H R; Theodos, C M; Markowitz, J S et al. (1995) Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. J Infect Dis 171:1302-8
|
|
Kuchroo, V K; Das, M P; Brown, J A et al. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-18
|
Showing the most recent 10 out of 39 publications
